logo
  • Über uns
    • Über uns
    • Führungsteam
    • Unsere Verantwortung
    • Kollaborationen
    • Unsere Standorte
  • Technologie
    • Technologie
    • Produktion
    • Publikationen
  • Pipeline
  • Newsroom
    • News
    • Events
    • Downloads
  • Investor Relations
    • Überblick
    • Analysten-Coverage
    • Hauptversammlung
    • Finanzberichte
    • Corporate Governance
    • E-Mail Alert
  • Karriere
    • Werden Sie Teil der RNA people
    • Ausbildung
    • Aktuelle Stellenangebote

Characterization of the ribonuclease activity on the skin surface

29. Mai 2006Mechanism of Action


by Sovereign

Vaccination with messenger RNA

1. Januar 2006Review Articles


by Sovereign

Human peripheral blood mononuclear cells transfected with messenger RNA stimulate antigen-specific cytotoxic T-lymphocytes in vitro

1. August 2005Mechanism of Action


by Sovereign

Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas

1. August 2005Mechanism of Action,Oncology


by Sovereign

Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA

1. Mai 2005Mechanism of Action


by Sovereign

RNA-based Therapies

27. Januar 2005Review Articles


by Sovereign

Co-transfection of messenger RNA and siRNA as a method to study the efficiency of siRNA

1. Januar 2005Mechanism of Action


by Sovereign

Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines

1. September 2004Mechanism of Action


by Sovereign

Messenger RNA-based vaccines

1. August 2004Review Articles


by Sovereign

Immunostimulating capacities of stabilized RNA molecules

1. Februar 2004Mechanism of Action


by Sovereign

  • 1
  • …
  • 3
  • 4
  • 5
  • 6